EQH Stock Analysis: Axa Equitable Holdings | NYSE
Asset Management | NYSE, USA | Market Cap: 14.003m USD | 12M Return: 4.7% | US29452E1010 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 128M
EPS Trend: 82.8%
Qual. Beats: 0
Rev. Trend: 48.2%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 8.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Equitable Holdings, Inc. (EQH) is a diversified financial services company headquartered in New York, operating through six business segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. The company primarily serves affluent and high-net-worth individuals through variable annuity products, while also providing retirement services to plans sponsored by educational entities, municipalities, non-profit organizations, and small-to-medium-sized businesses. Its offerings span investment management, life insurance (including VUL, COLI, IUL, and term life), employee benefits, and advisory/financial planning services, with the Legacy segment housing its capital-intensive fixed-rate GMxB business. The company was founded in 1859, was formerly known as AXA Equitable Holdings, Inc., and adopted its current name in January 2020.
As a large-cap U.S. financials company listed on the NYSE, EQH operates within the diversified financial services sub-industry, generating revenue through a mix of insurance premiums, asset-based fees, and advisory commissions. Variable annuities, a core product for the firm, are hybrid insurance-investment contracts that have faced increased regulatory scrutiny in recent years regarding living and death benefit guarantees.
- Interest rate path drives spread income and hedging costs
- Equity market gains lift Asset Management AUM and fees
- Legacy GMxB runoff releases capital for shareholder returns
| Net Income: -926.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.52 > 1.0 |
| NWC/Revenue: 33.83% < 20% (prev -506.9%; Δ 540.8% < -1%) |
| CFO/TA 0.00 > 3% & CFO 840.0m > Net Income -926.0m |
| Net Debt (-136b) to EBITDA (2.24b): -60.98 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (283.8m) vs 12m ago -6.40% < -2% |
| Gross Margin: 77.80% > 18% (prev 66.96%; Δ 10.84% > 0.5%) |
| Asset Turnover: 3.86% > 50% (prev 4.24%; Δ -0.38% > 0%) |
| Interest Coverage Ratio: 6.04 > 6 (EBIT TTM 1.37b / Interest Expense TTM 226.0m) |
| A: 0.01 (Total Current Assets 143b - Total Current Liabilities 139b) / Total Assets 335b |
| B: 0.02 (Retained Earnings 8.37b / Total Assets 335b) |
| C: 0.00 (EBIT TTM 1.37b / Avg Total Assets 319b) |
| D: -0.00 (Book Value of Equity -785.0m / Total Liabilities 333b) |
| Altman-Z'' = 0.19 = B |
As of August 07, 2026, the stock is trading at USD 52.17 with a total of 3,092,482 shares traded. Over the past week, the price has changed by +7.41%, over one month by +10.57%, over three months by +20.96% and over the past year by +4.73%.
Current recommended Stop Loss: 48.10 (which is 7.8% or 2.6 ATR below the current price).
Axa Equitable Holdings has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy EQH.
- StrongBuy: 6
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 60.8 | 16.6% |
P/E Forward = 4.5851
P/S = 1.3185
P/B = 164.1395
Revenue TTM = 12.3b USD
EBIT TTM = 1.37b USD
EBITDA TTM = 2.24b USD
Long Term Debt = 6.54b USD (from longTermDebt, last fiscal year)
Short Term Debt = 25.0m USD (from shortTermDebt, last fiscal year)
Debt = 6.56b USD (corrected: LT Debt 6.54b + ST Debt 25.0m)
Net Debt = -136b USD (calculated: Debt 6.56b - CCE 143b)
Enterprise Value = 14.0b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 6.04 (Ebit TTM 1.37b / Interest Expense TTM 226.0m)
EV/FCF = 17.35x (Enterprise Value 14.0b / FCF TTM 807.0m)
FCF Yield = 5.76% (FCF TTM 807.0m / Enterprise Value 14.0b)
FCF Margin = 6.55% (FCF TTM 807.0m / Revenue TTM 12.3b)
Net Margin = -7.52% (Net Income TTM -926.0m / Revenue TTM 12.3b)
Gross Margin = 77.80% ((Revenue TTM 12.3b - Cost of Revenue TTM 2.73b) / Revenue TTM)
Gross Margin QoQ = 92.45% (prev 90.69%)
Tobins Q-Ratio = 0.04 (Enterprise Value 14.0b / Total Assets 335b)
Interest Expense / Debt = 3.44% (Interest Expense 226.0m / Debt 6.56b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 1.08b (EBIT 1.37b * (1 - 21.00%))
Current Ratio = 1.03 (Total Current Assets 143b / Total Current Liabilities 139b)
Debt / Equity = -8.36 (negative equity) (Debt 6.56b / totalStockholderEquity, last quarter -785.0m)
Debt / EBITDA = -60.98 (Net Debt -136b / EBITDA 2.24b)
Debt / FCF = -169.1 (out of range, set to none) (Net Debt -136b / FCF TTM 807.0m)
Total Stockholder Equity = -109.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.29% (Net Income -926.0m / Total Assets 335b)
RoE = 845.7% (negative equity) (Net Income TTM -926.0m / Total Stockholder Equity -109.5m)
RoCE = 21.25% (EBIT 1.37b / Capital Employed (Equity -109.5m + L.T.Debt 6.54b))
RoIC = 0.55% (NOPAT 1.08b / Invested Capital 195b)
WACC = 7.72% (E(14.0b)/V(20.6b) * Re(10.06%) + D(6.56b)/V(20.6b) * Rd(3.44%) * (1-Tc(0.21)))
Discount Rate = 10.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.75 | Cagr: -6.82%
[DCF] Terminal Value 73.10% ; FCFF base≈1.41b ; Y1≈1.23b ; Y5≈996.3m
[DCF] Fair Price = 558.6 (EV 16.0b - Net Debt -136b = Equity 152b / Shares 273.0m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 82.76 | EPS CAGR: 10.74% | SUE: 0.44 | # QB: 0
Revenue Correlation: 48.22 | Revenue CAGR: 5.17% | SUE: -0.32 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.90 | Chg30d=+3.37% | Revisions=+44% | Analysts=10
EPS current Year (2026-12-31): EPS=7.15 | Chg30d=+1.00% | Revisions=+42% | GrowthEPS=+26.7% | GrowthRev=+33.0%
EPS next Year (2027-12-31): EPS=8.93 | Chg30d=+1.34% | Revisions=+55% | GrowthEPS=+24.9% | GrowthRev=+9.0%
[Analyst] Revisions Ratio: +58% (up=19, down=4)